4//SEC Filing
Kassler-Taub Kenneth B. 4
Accession 0001127602-23-007925
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:51 PM ET
Size
15.6 KB
Accession
0001127602-23-007925
Insider Transaction Report
Form 4
Kassler-Taub Kenneth B.
SVP, Regulatory & QA
Transactions
- Exercise/Conversion
Common Stock
2023-02-28+7,086→ 111,186 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−18,243→ 0 total→ Common Stock (18,243 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-28−27,557→ 55,113 total→ Common Stock (27,557 underlying) - Exercise/Conversion
Common Stock
2023-02-28+18,243→ 104,100 total - Exercise/Conversion
Common Stock
2023-02-28+27,557→ 138,743 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−7,086→ 7,087 total→ Common Stock (7,086 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−19,118$41,486→ 119,625 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001885219
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:51 PM ET
- Size
- 15.6 KB